Return to homepagePandemic Pact

INSIGHT: Developing reagents for COVID-19 diagnosis and mutational analysis

Grant number: CV009

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Funder

    Wellcome Trust

  • Principal Investigator

    Pending

  • Research Location

    United Kingdom

  • Lead Research Institution

    Wellcome Sanger Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Development of a two-stage testing assay for the COVID-19 pathogen. Fluorescent/dipstick-based viral RNA detection first stage (10-100 copies detected) and a centralised sequencing second stage to further improve the accuracy of the test. This two-stage testing strategy may be suitable as a home-based or point-of-care assay.